Differential regulation of the cloned kappa and mu opioid receptors

M Tallent1, M A Dichter, T Reisine

  • 1Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

Neuroscience
|June 25, 1998
PubMed

Insights

The kappa opioid receptor shows homologous regulation, while the mu opioid receptor undergoes heterologous desensitization when expressed in the same cells. This difference in opioid receptor regulation may impact addiction and tolerance.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Opioid receptors (kappa and mu) are crucial for pain modulation and mediate diverse physiological effects.
  • Understanding opioid receptor regulation is key to developing safer analgesics and addiction therapies.
  • Previous studies have investigated kappa and mu opioid receptor signaling independently.

Purpose of the Study:

  • To directly compare the regulatory mechanisms of cloned kappa and mu opioid receptors in the same cellular environment.
  • To investigate the homologous versus heterologous desensitization of kappa and mu opioid receptors.
  • To elucidate the differential coupling of kappa and mu opioid receptors to distinct signaling pathways.

Main Methods:

  • Expression of cloned kappa and mu opioid receptors in the mouse anterior pituitary cell line AtT-20.
  • Utilizing the well-characterized endogenous somatostatin receptor signaling to adenylyl cyclase and K+ current as a reference.
  • Employing agonist pretreatment to assess receptor uncoupling and desensitization of functional responses.

Main Results:

  • Kappa opioid receptor readily uncoupled from both K+ current and adenylyl cyclase, exhibiting homologous desensitization.
  • Mu opioid receptor uncoupled from K+ current but not adenylyl cyclase, displaying heterologous desensitization.
  • Somatostatin agonist pretreatment caused mu receptor uncoupling but not kappa receptor uncoupling from the K+ current.

Conclusions:

  • Kappa and mu opioid receptors exhibit distinct regulatory patterns within the same cell line.
  • Mu opioid receptor desensitization affects broader downstream signaling pathways compared to kappa receptor.
  • Differential regulation of kappa and mu opioid receptors may underlie variations in addiction, tolerance, and withdrawal responses to opioid drugs.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...